Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus

Journal of Rheumatology

Volumn 31, Issue 11, 2004, Pages 2151-2155

  Park, Hyung Bae ^a   Kim, Ki Chan ^a   Park, Jae Hong ^a   Kang, Tae Young ^a   Lee, Hye Soon ^a   Kim, Tae Hwan ^a   Jun, Jae Bum ^a   Bae, Sang Cheol ^a   Yoo, Dae Hyun ^a   Craft, Joe ^b   Jung, Sungsoo ^a  

^a Hanyang University College of Medicine   (South Korea)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD4 T cell; Herpes zoster; Systemic lupus erythematosus; Varicella zoster virus

Indexed keywords

AZATHIOPRINE; CD4 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FLOW CYTOMETRY; HERPES ZOSTER; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; INCIDENCE; MEMORY CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STAINING; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; VARICELLA ZOSTER VIRUS;

ADOLESCENT; ADULT; ANTIGENS, VIRAL; ARTHRITIS, RHEUMATOID; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FLOW CYTOMETRY; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOLOGIC MEMORY; KOREA; LUPUS ERYTHEMATOSUS, SYSTEMIC; SEROEPIDEMIOLOGIC STUDIES; VIRAL ENVELOPE PROTEINS;

EID: 7544234550     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Arvin AM. Varicella-zoster virus. In: Fields B, Knipe D, Howley P, editors. Fields virology. New York: Raven Press; 1995:2547-86.
2. Lungu O, Annunziato PW, Gershon A, et al. Reactivated and latent varicella-zoster virus in human dorsal root ganglia. Proc Natl Acad Sci USA 1995;92:10980-4.
3. Weller TH. Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus. N Engl J Med 1983;309:1362-8.
4. Ragozzino MW, Melton LJ, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982;61:310-6.
5. Straus SE, Ostrove JM, Inchauspe G, et al. Varicella-zoster virus infections: biology, natural history, treatment and prevention. Ann Intern Med 1988;108:221-7.
6. Ginzler E, Diamond H, Kaplan D, Weiner M, Schlesinger M, Seleznick M. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 1978;21:37-44.
7. Moutsopoulos HM, Gallagher JD, Decker JL, Steinberg AD. Herpes zoster in patients with systemic lupus erythematosus. Arthritis Rheum 1978;21:798-802.
8. Nagasawa K, Yamauchi Y, Tada Y, Kusaba T, Niho Y, Yoshikawa H. High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis. Ann Rheum Dis 1990;49:630-3.
9. Manzi S, Kutzer J, Ramsey-Goldman R, Kuller L, Medsger T. The epidemiology of herpes zoster in systemic lupus erythematosus [abstract]. Arthritis Rheum 1992;35 Suppl:S240.
10. Kahl LE. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome. J Rheumatol 1994;21:84-6.
11. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
12. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
13. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
14. Fellows of Harvard College, SLE Activity Measure-Revised (SLAM-R), 1988, Revised July 1991
15. Suni MA, Picker LJ, Maino VC. Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry. J Immunol Methods 1988;212:89-98.
16. Asanuma H, Sharp M, Maecker HT, Maino VC, Arvin AM. Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression. J Infect Dis 2000;181:859-66.
17. Levin MJ, Hayward AR. The varicella vaccine. Prevention of herpes zoster. Infect Dis Clin North Am 1996;10:657-75.
18. Jenkins DE, Redman RL, Lam EM, Liu C, Lin I, Arvin AM. Interleukin (IL)-10, IL-12 and interferon gamma production in primary and memory immune responses to varicella-zoster virus. J Infect Dis 1998;178:940-8.
19. Yokota S, Geppert TD, Lipsky PE. Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor alpha. J Immunol 1988;140:531-6.
20. Matloubian M, Concepcion RJ, Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 1994;68:8056-63.
21. von Herrath MG, Yokoyama M, Dockter J, Oldstone MBA, Whitton JL. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J Virol 1996;70:1072-9.
22. Ridge JP, Rosa FD, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 1998;393:474-8.
23. Zhang Y, Cosyns M, Levin MJ, Hayward AR. Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin Exp Immunol 1994;98:128-33.
24. Hayward AR, Cosyns M, Jones M, et al. Cytokine production in varicella-zoster virus-stimulated cultures of human blood lymphocytes. J Infect Dis 1998;178 Suppl 1:S95-8.
25. Boss JM. Regulation of transcription of MHC class II genes. Curr Opin Immunol 1997;9:107-13.
26. Miller DM, Rahill BM, Boss JM, et al. Human cytomegalovirus inhibits MHC class II expression by disruption of the Jak/Stat pathway. J Exp Med 1998;187:675-83.
27. Le Roy E, Muhlethaler-Mottet A, Davrinche C, Mach B, Davignon J. Escape of human cytomegalovirus from HLA-DR-restricted CD4+ T cell response is mediated by repression of g interferon-induced class II transactivator expression. J Virol 1999;73:6582-9.
28. Abendroth A, Arvin AM. Immune evasion as a pathogenic mechanism of varicella zoster virus. Semin Immunol 2001;13:27-39.
29. Ploegh HL. Viral strategies of immune evasion. Science 1998;280:248-53.
30. Rozzo SJ, Drake CG, Chiang BL, Gershwin ME, Kotzin BL. Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus. J Immunol 1994;153:1340-51.
31. Tsokos GC, Liossis SNC. Immune cell signaling defects in lupus: activation, anergy and death. Immunol Today 1999;20:119-24.
32. Kammer GM, Perl A, Richardson BC, Tsokos GC. Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum 2002;46:1139-54.
33. Jung S, Vratsanos GS, Park Y, Craft J. CD4+ T cells from lupus-prone mice are hyperresponsive to T cell receptor engagement with low and high affinity peptide antigens: a model to explain spontaneous T cell activation in lupus. J Exp Med 2001;193:329-37.